706 |
Registers & Documentation at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
712 |
Monitoring of ACF campaign |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
740 |
TB Treatment Card |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
741 |
NTEP TB ID Card |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
742 |
Transfer of TB Patient Ownership |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
743 |
Treatment Support Plan |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
798 |
Recording Adherence in Treatment card |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
806 |
99 DOTS |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
807 |
99 DOTS- Features and Benefits |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
808 |
99 DOTS- Envelopes |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
814 |
Monitoring of Adherence by NTEP Staff |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
815 |
Monitoring of Adherence by Pateint/TS |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
816 |
Adherence Summary Dashboard |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
819 |
Support for Rehabilitation |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
820 |
Support for deaddiction |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
821 |
Travel support for people with TB |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
822 |
Free Drugs and Free Treatment |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
837 |
Planning Process at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
838 |
Supportive Supervision |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
839 |
Supervision, Monitoring and Evaluation |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
841 |
Maintenance of records - NTEP Drug Stock Register |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1078 |
Formats used for monitoring [NTEP] |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1089 |
Causality Assessment for ADR Reporting |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1090 |
Causality Assessment: WHO-UMC [UPSALA Monitoring Centre] Causality Categories for ADR Reporting |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1091 |
Severity Criteria for Reporting ADRs |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1633 |
Supervisory checklist for TB Unit/ Microscopy Centre/ PHI - Health Facility |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1634 |
Supervision by MO-TC at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1635 |
Supervision by DTO at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1641 |
Program Monitoring Indicators |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
1642 |
NTEP TB Index - Indicators |
05/06/2024 |
Surveillance, SM&E and Epidemiology |